459 related articles for article (PubMed ID: 25936567)
1. Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma.
Larose MC; Chakir J; Archambault AS; Joubert P; Provost V; Laviolette M; Flamand N
J Allergy Clin Immunol; 2015 Oct; 136(4):904-13. PubMed ID: 25936567
[TBL] [Abstract][Full Text] [Related]
2. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge.
Ravensberg AJ; Ricciardolo FL; van Schadewijk A; Rabe KF; Sterk PJ; Hiemstra PS; Mauad T
J Allergy Clin Immunol; 2005 Apr; 115(4):779-85. PubMed ID: 15805998
[TBL] [Abstract][Full Text] [Related]
3. Epithelial SERPINB10, a novel marker of airway eosinophilia in asthma, contributes to allergic airway inflammation.
Mo Y; Zhang K; Feng Y; Yi L; Liang Y; Wu W; Zhao J; Zhang Z; Xu Y; Hu Q; He J; Zhen G
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L245-L254. PubMed ID: 30382768
[TBL] [Abstract][Full Text] [Related]
4. Decreased epithelial and sputum miR-221-3p associates with airway eosinophilic inflammation and CXCL17 expression in asthma.
Zhang K; Liang Y; Feng Y; Wu W; Zhang H; He J; Hu Q; Zhao J; Xu Y; Liu Z; Zhen G
Am J Physiol Lung Cell Mol Physiol; 2018 Aug; 315(2):L253-L264. PubMed ID: 29644894
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
6. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.
Létuvé S; Lajoie-Kadoch S; Audusseau S; Rothenberg ME; Fiset PO; Ludwig MS; Hamid Q
J Allergy Clin Immunol; 2006 Mar; 117(3):590-6. PubMed ID: 16522458
[TBL] [Abstract][Full Text] [Related]
7. Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma.
Doran E; Choy DF; Shikotra A; Butler CA; O'Rourke DM; Johnston JA; Kissenpfennig A; Bradding P; Arron JR; Heaney LG
Eur Respir J; 2016 Sep; 48(3):715-25. PubMed ID: 27338192
[TBL] [Abstract][Full Text] [Related]
8. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
Lemière C; Ernst P; Olivenstein R; Yamauchi Y; Govindaraju K; Ludwig MS; Martin JG; Hamid Q
J Allergy Clin Immunol; 2006 Nov; 118(5):1033-9. PubMed ID: 17088126
[TBL] [Abstract][Full Text] [Related]
9. Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset.
Coleman JM; Naik C; Holguin F; Ray A; Ray P; Trudeau JB; Wenzel SE
Thorax; 2012 Dec; 67(12):1061-6. PubMed ID: 23015684
[TBL] [Abstract][Full Text] [Related]
10. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.
Lucendo AJ; De Rezende L; Comas C; Caballero T; Bellón T
Am J Gastroenterol; 2008 Sep; 103(9):2184-93. PubMed ID: 18844613
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation.
Gauvreau GM; Watson RM; O'Byrne PM
Am J Respir Crit Care Med; 1999 Aug; 160(2):640-7. PubMed ID: 10430741
[TBL] [Abstract][Full Text] [Related]
12. Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.
Silkoff PE; Laviolette M; Singh D; FitzGerald JM; Kelsen S; Backer V; Porsbjerg CM; Girodet PO; Berger P; Kline JN; Chupp G; Susulic VS; Barnathan ES; Baribaud F; Loza MJ;
J Allergy Clin Immunol; 2017 Sep; 140(3):710-719. PubMed ID: 28089872
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26).
Heiman AS; Abonyo BO; Darling-Reed SF; Alexander MS
J Interferon Cytokine Res; 2005 Feb; 25(2):82-91. PubMed ID: 15695929
[TBL] [Abstract][Full Text] [Related]
14. Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
Berry MA; Parker D; Neale N; Woodman L; Morgan A; Monk P; Bradding P; Wardlaw AJ; Pavord ID; Brightling CE
J Allergy Clin Immunol; 2004 Nov; 114(5):1106-9. PubMed ID: 15536417
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells.
Ying S; Robinson DS; Meng Q; Rottman J; Kennedy R; Ringler DJ; Mackay CR; Daugherty BL; Springer MS; Durham SR; Williams TJ; Kay AB
Eur J Immunol; 1997 Dec; 27(12):3507-16. PubMed ID: 9464841
[TBL] [Abstract][Full Text] [Related]
16. [Relation between clinical severity of bronchial asthma and degree of airway inflammation assessed by the eosinophilic leukocyte count in induced sputum].
Chlumský J; Pokorná H
Vnitr Lek; 2001 Sep; 47(9):604-8. PubMed ID: 11715664
[TBL] [Abstract][Full Text] [Related]
17. Blackcurrant proanthocyanidins augment IFN-gamma-induced suppression of IL-4 stimulated CCL26 secretion in alveolar epithelial cells.
Hurst SM; McGhie TK; Cooney JM; Jensen DJ; Gould EM; Lyall KA; Hurst RD
Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S159-70. PubMed ID: 20229526
[TBL] [Abstract][Full Text] [Related]
18. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells.
Komiya A; Nagase H; Yamada H; Sekiya T; Yamaguchi M; Sano Y; Hanai N; Furuya A; Ohta K; Matsushima K; Yoshie O; Yamamoto K; Hirai K
Cell Immunol; 2003 Oct; 225(2):91-100. PubMed ID: 14698143
[TBL] [Abstract][Full Text] [Related]
19. Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa.
Fukakusa M; Bergeron C; Tulic MK; Fiset PO; Al Dewachi O; Laviolette M; Hamid Q; Chakir J
J Allergy Clin Immunol; 2005 Feb; 115(2):280-6. PubMed ID: 15696082
[TBL] [Abstract][Full Text] [Related]
20. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum.
Dent G; Hadjicharalambous C; Yoshikawa T; Handy RL; Powell J; Anderson IK; Louis R; Davies DE; Djukanovic R
Am J Respir Crit Care Med; 2004 May; 169(10):1110-7. PubMed ID: 15001461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
